Nang Kuang Pharmaceutical Co., Ltd.
1752.TW
Price:
$38.25
Market Cap:
$3.86B
Nang Kuang Pharmaceutical Co., Ltd. operates as a pharmaceutical company primarily in Taiwan. The company provides parenterals, aseptic parenterals, lyophilized injections, pre-filled syringes, and pre-mixed IV infusion bags, as well as tablets, capsules, topical products, and oral suspensions. It offers various products in the areas of cardiovascular system, gastrointestinal system, nervous system, alimentary and metabolism, blood, antineoplastic and immunomodulatory, musculo-skeletal system, respiratory system, dermatological, genito-urinary and sex hormone, systemic hormone, systemic antibacterial, and cosmetics, as well as hospital solution. In addition, the company offers sterile, antic...[Read more]
Industry
Medical - Instruments & Supplies
IPO Date
2022-01-20
Stock Exchange
TAI
Ticker
1752.TW
PE Ratio
[15.06]
ROE
[11.34%]
Current Ratio
[1.27]
Dividend Yield
[4.18%]
Enterprise Value
[4.16B]
Dividend History
The ROE as of December 2025 (TTM) for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) is 11.34%
According to Nang Kuang Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 11.34%. This represents a change of 300.48% compared to the average of 2.83% of the last 4 quarters.
Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) Historical ROE (quarterly & annually)
How has 1752.TW ROE performed in the past?
The mean historical ROE of Nang Kuang Pharmaceutical Co., Ltd. over the last ten years is 9.42%. The current 11.34% ROE has changed 20.39% with respect to the historical average. Over the past ten years (40 quarters), 1752.TW's ROE was at its highest in in the December 2022 quarter at 6.71%. The ROE was at its lowest in in the December 2023 quarter at -1.46%.
Average
9.42%
Median
9.35%
Minimum
4.93%
Maximum
14.60%
Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) ROE by Quarter and Year
Discovering the peaks and valleys of Nang Kuang Pharmaceutical Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 113.75%
Maximum Annual ROE = 14.60%
Minimum Annual Increase = -43.13%
Minimum Annual ROE = 4.93%
| Year | ROE | Change |
|---|---|---|
| 2024 | 10.05% | 20.41% |
| 2023 | 8.35% | -42.83% |
| 2022 | 14.60% | 66.77% |
| 2021 | 8.75% | 5.23% |
| 2020 | 8.32% | -16.32% |
| 2019 | 9.94% | 101.62% |
| 2018 | 4.93% | -43.13% |
| 2017 | 8.67% | -18.37% |
| 2016 | 10.62% | 6.45% |
| 2015 | 9.98% | 113.75% |
Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) Average ROE
How has 1752.TW ROE performed in the past?
The current ROE of Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.00%
5-year avg
10.01%
10-year avg
9.42%
Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) ROE vs. Peers
How is 1752.TW’s ROE compared to its peers?
Nang Kuang Pharmaceutical Co., Ltd.’s ROE is less than Maxigen Biotech Inc. (14.86%), less than ICARES Medicus, Inc. (5.75%), greater than Bionime Corporation (-6.07%), less than Synbio Tech Inc. (16.47%), less than Syngen Biotech Co.,Ltd. (12.66%), greater than Orient EuroPharma Co., Ltd. (-5.85%), greater than BRIM Biotechnology, Inc. (-11.90%), greater than ACRO Biomedical Co., Ltd. (-16.18%), greater than Energenesis Biomedical CO.,LTD. (-32.50%), less than SYN-TECH Chem. & Pharm. Co., Ltd. (12.18%),
| Company | ROE | Market cap |
|---|---|---|
| 14.86% | $3.88B | |
| 5.75% | $3.93B | |
| -6.07% | $3.96B | |
| 16.47% | $3.23B | |
| 12.66% | $3.52B | |
| -5.85% | $3.89B | |
| -11.90% | $3.72B | |
| -16.18% | $4.23B | |
| -32.50% | $3.92B | |
| 12.18% | $3.43B |
Build a custom stock screener for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nang Kuang Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Nang Kuang Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Nang Kuang Pharmaceutical Co., Ltd.'s ROE?
How is the ROE calculated for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)?
What is the highest ROE for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)?
What is the 3-year average ROE for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)?
What is the 5-year average ROE for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)?
How does the current ROE for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) compare to its historical average?